Joshua T. Brumm, CEO & President at Dyne Therapeutics, Inc. (DYN), sold 523,412 shares at $18.34 ($9.7M) on 2024-01-03, disclosed to the SEC on 2024-01-04.
Scheduled sale ($9.7M) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.34 | 15,382 | $282K | 2.9% |
| 2 | $18.34 | 15,382 | $282K | 2.9% |
| 3 | $19.03 | 19,775 | $376K | 3.9% |
| 4 | $19.03 | 19,775 | $376K | 3.9% |
| 5 | $20.50 | 16,026 | $329K | 3.4% |
| 6 | $18.40 | 180,235 |
| $3.3M |
| 34.1% |
| 7 | $18.40 | 180,235 | $3.3M | 34.1% |
| 8 | $19.05 | 38,301 | $730K | 7.5% |
| 9 | $19.05 | 38,301 | $730K | 7.5% |
| Total | $18.60 avg | 523,412 | $9.7M | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |